Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07753265 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study on the Live-Attenuated Herpes Zoster Vaccine for Sequential Booster Immunization Following Recombinant Herpes Zoster Vaccine

StatusNot Yet Recruiting
PhaseEarly Phase 1
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated August 7, 2026 (before its estimated September 20, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
Evaluate the immunogenicity after boost vaccination with the live attenuated herpes zoster vaccine.
Trial Details
NCT Number NCT07753265
Lead Sponsor Changchun BCHT Biotechnology Co.
Conditions
(from sponsor)		 Herpse Zoster
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov